Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 12/17/14  and contains information from public web pages and contributions from the ZoomInfo community.


Local Address: United Kingdom
333 Bay Street Suite 4600
Toronto , Ontario M5H 2S5

Company Description: KPMG LLP, an Audit, Tax and Advisory firm ( and a Canadian limited liability partnership established under the laws of Ontario, is the Canadian member firm...   more

Employment History

  • European Head of Chemicals and Pharmaceuticals
43 Total References
Web References
Chris Stirling, UK Head of ..., 27 Oct 2014 [cached]
Chris Stirling, UK Head of Life Sciences for KPMG LLP, said: "To ensure continued investment in research and development, life sciences companies need to review their management and exploitation of intellectual property. They need to make sure that the true value generated from each location and activity is fully recognized and remunerated. The proposals could have the potential to significantly impact the bottom line of a large number of life sciences companies."
Stirling said that life science companies should consider four actions to assess the likely impact on their operations of the BEPS project:
Properly planned for, companies could simplify the choice of location for production, distribution, R&D and sales and marketing," Stirling said.
Chris ..., 1 July 2014 [cached]
Chris Sterling KPMG's Chris Sterling giving a talk. Picture Source:
The global head of KPMG's life ..., 1 July 2014 [cached]
The global head of KPMG's life sciences practice, Chris Stirling, has suggested that in order to maintain profits and a healthy industry, the Pharma sector needs to make big changes to its business model. According to the firm's research, return on R&D expenditure has halved in the past 20 years and the earnings ratios on products have also fallen dramatically.
Commenting on the findings Mr. Stirling said "The business model that has powered the pharma industry over the last few decades is showing signs of fatigue - costs are skyrocketing, breakthrough innovation is ebbing, competition is intense and sales growth is flattening".
Mr. Stirling highlights a lack of focus on the patient and that there is instead an over-reliance on blockbuster products which as various reports have shown, are no longer giving the return on investment they once did.
Mr. Stirling talked about changing the system from a "value chain" to a "value ecosystem" whereby many aspects of a business are wrapped around the patient at its core.
"If the pharmaceutical industry is to capitalise upon this potential, it must innovate to develop new business models and find better ways to collaborate across the healthcare ecosystem - all the while putting the patient at the heart of everything it does," concluded Mr. Stirling.
Finance & Investment Industry News | Alliance Trust Savings Adviser, 11 Dec 2014 [cached]
Although Pfizer is reported to be planning a follow-up bid for Astra Zeneca, and if such a deal went ahead it would be classified as a mega deal, Chris Stirling, global head of KPMG's life sciences practice, has said we could be seeing the end of mega deals in the pharmaceutical industry.
Mr Stirling's comments follow news that GSK is to buy Novartis's vaccine business for $7.1 billion and sell its cancer drug portfolio to Novartis for $16 billion. The two companies are planning a health care joint venture combining such products as GSK's Sensodyne toothpaste and Novartis's Otrivine nasal spray.
Mr Stirling said: "We are…seeing companies learn the lessons of the past.
Chris Stirling, head of life ..., 27 April 2014 [cached]
Chris Stirling, head of life sciences at KPMG, says the asset swap could be a game-changer for the industry: "We are seeing companies learn the lessons of the past.
Other People with the name "Stirling":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.